Organoselenocyanate-Conjugated NBDHEX Derivatives as Potent Anticancer Agents for the Treatment of Breast Cancer via ROS-Regulated Signaling Pathways
ACS Applied Bio Materials · 2025
DOI: 10.1021/acsabm.5c02154 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2025. Verfasst von Nikita Pal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India. Hauptthemen laut MEDLINE: Antineoplastic Agents, Organoselenium Compounds, Breast Neoplasms, Reactive Oxygen Species. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Indian Institute of Technology Guwahati, Science and Engineering Research Board, Ministry of Education, India.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India.
- Department of Chemical Engineering, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India.
ORCID-Profile: Krishna P Bhabak
Förderung
- Indian Institute of Technology Guwahati
- Science and Engineering Research Board
- Ministry of Education, India
Zitieren
APA
Pal, N., Kesarwani, R., Mandal, T. K., & Bhabak, K. P. (2025). Organoselenocyanate-Conjugated NBDHEX Derivatives as Potent Anticancer Agents for the Treatment of Breast Cancer via ROS-Regulated Signaling Pathways. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c02154
Vancouver
Pal N, Kesarwani R, Mandal TK, Bhabak KP. Organoselenocyanate-Conjugated NBDHEX Derivatives as Potent Anticancer Agents for the Treatment of Breast Cancer via ROS-Regulated Signaling Pathways. ACS Applied Bio Materials. 2025. doi:10.1021/acsabm.5c02154
BibTeX
@article{Pal2025,
author = {Pal, Nikita and Kesarwani, Rahul and Mandal, Tapas K and Bhabak, Krishna P},
title = {Organoselenocyanate-Conjugated NBDHEX Derivatives as Potent Anticancer Agents for the Treatment of Breast Cancer via ROS-Regulated Signaling Pathways},
journal = {ACS Applied Bio Materials},
year = {2025},
doi = {10.1021/acsabm.5c02154}
}
EUVIMED